We’re here
to help.

FemaSeed is currently offered by a growing network of OB/GYNs and fertility specialists across the United States. If you are interested in finding a physician near you, please contact Femasys Customer Service or use the provider locator on the FemaSeed website, if available. Our team can help connect you with a practice offering FemaSeed in your area.

Fertility coverage varies by insurance plan and state, and many states provide limited or no coverage for fertility procedures. As a result, FemaSeed will likely be a self-pay procedure. Patients may contact their insurance provider directly to determine whether any portion of the procedure is covered under their specific plan.

Femasys provides comprehensive clinical education and product training for healthcare professionals interested in offering FemaSeed or FemVue. Training may include in-person instruction, virtual education, and hands-on procedural support. To schedule training or learn more, please contact your Femasys sales representative or Customer Service.

1-877-336-2562 →

[email protected] →

Current SEC filings, quarterly and annual financial reports, investor presentations, press releases, and other shareholder information are available on the Investor Relations section of the Femasys website.

FemBloc is not currently commercially available in the United States. The device is being evaluated in the FDA-authorized FINALE pivotal clinical trial to support potential U.S. approval.